辅助剂塞米普利马布或安慰剂在高风险的皮肤状细胞癌中
Danny Rischin1,2, Sandro Porceddu3, Fiona Day4
1Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
The New England journal of medicine
|June 2, 2025
概括
辅助性塞米普利马布显著改善了患有高风险皮肤状细胞癌的患者的无病生存率. 这种全身疗法在3期试验中,与安慰剂相比,降低了复发或死亡的风险.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 临床试验 临床试验
背景情况:
- 具有高风险特征的皮肤状细胞癌 (cSCC) 具有治疗后复发风险.
- 对于这些患者来说,系统辅助治疗的益处仍然未确立.
研究的目的:
- 评估辅助剂塞米普利马布与安慰剂在预防高风险cSCC复发方面的疗效.
主要方法:
- 一个第三阶段的随机试验招募了415名手术后和放射治疗后患有高风险cSCC的患者.
- 患者在长达48周的时间内静脉注射塞米普利马布或安慰剂.
- 主要终点是无病生存期;次要终点包括复发和安全性.
主要成果:
- 与安慰剂 (64.1%) 相比,塞米普利马布显示出更高的无疾病生存率 (87.1%在24个月内).
- 复发或死亡的危险比为0.32与塞米普利马布 (P<0.001).
- 塞米普利马布显著降低了局部和远程复发风险;更严重的不良事件发生的频率更高.
结论:
- 辅助塞米普利马布治疗显著提高高风险cSCC患者的无病生存率.
- 塞米普利马布是预防cSCC复发的有希望的系统选择.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.7K
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
10.7K
相关概念视频
01:30Skin Cancer
4.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.6K
01:27Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278